GoodRx
GDRX
2.92
-0.10
-3.31%
GoodRx
US · GDRX
#3178 by market cap
Listed 2020
2.92
-0.10
-3.31%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:50
Quant vs Street three independent views, side by side
StockVane factor grade
C-
Momentum strategy signal
Hold
Analyst consensus
Sell
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: J.P. Morgan moved from Buy to Hold on 2026-02-26.
Analyst consensus 1 analysts
Sell
Avg price target 2.65 -9.2%
Price target rangecurrent 2.92
Low2.65
Avg2.65
High2.65
Buy 0%
Hold 0%
Sell 100%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-15 | BofA Securities | -- | Sell | 2.65 |
| 2026-08-25 | BofA Securities | -- | Sell | 2.65 |
| 2026-08-14 | Truist Financial | -- | Hold | -- |
| 2026-08-13 | UBS | -- | Hold | 3.75 |
| 2026-08-11 | TD Cowen | -- | Buy | 5.00 |
| 2026-08-11 | Citi | -- | Buy | 5.00 |
| 2026-08-10 | TD Cowen | -- | Buy | 5.00 |
| 2026-08-10 | Citi | -- | Buy | 5.00 |
| 2026-08-07 | Raymond James | -- | Buy | 4.50 |
| 2026-08-07 | Morgan Stanley | -- | Hold | 4.00 |
| 2026-08-07 | Goldman Sachs | -- | Hold | 4.00 |
| 2026-08-06 | Truist Financial | -- | Hold | -- |
| 2026-08-06 | Citi | -- | Buy | 4.00 |
| 2026-08-06 | Leerink Partners | -- | Buy | 5.00 |
| 2026-07-23 | Citi | -- | Buy | 4.00 |
| 2026-06-23 | Truist Financial | -- | Hold | -- |
| 2026-06-02 | Wells Fargo | -- | Buy | 3.50 |
| 2026-05-15 | Truist Financial | -- | Hold | -- |
| 2026-05-14 | Citi | -- | Buy | 4.00 |
| 2026-05-11 | TD Cowen | -- | Buy | 4.00 |
| 2026-05-10 | TD Cowen | -- | Buy | 4.00 |
| 2026-05-08 | Wells Fargo | -- | Buy | 3.50 |
| 2026-05-08 | Goldman Sachs | -- | Hold | 3.50 |
| 2026-05-07 | Truist Financial | -- | Hold | -- |
| 2026-05-06 | Raymond James | -- | Buy | -- |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-02-26 | J.P. Morgan | Buy → Hold | -- |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-05 | After close | -- | +13.76% |
| 2026/Q1 | 2026-05-06 | After close | ±14.59% | +10.51% (in line) |
| 2025/Q4 | 2026-02-25 | After close | ±20.41% | -18.78% (in line) |
| 2025/Q3 | 2025-11-04 | After close | ±39.12% | +2.15% (in line) |
| 2025/Q2 | 2025-08-06 | After close | ±19.59% | -20.05% (beat) |
| 2025/Q1 | 2025-05-07 | After close | ±35.12% | +11.87% (in line) |
| 2024/Q4 | 2025-02-27 | -- | ±29.82% | +1.84% (in line) |
| 2024/Q3 | 2024-11-07 | -- | ±22.09% | -17.51% (in line) |
| 2024/Q2 | 2024-08-08 | -- | ±17.89% | -18.58% (beat) |
| 2024/Q1 | 2024-05-09 | -- | ±20.08% | -8.94% (in line) |
| 2023/Q4 | 2024-02-29 | -- | ±24.56% | +20.40% (in line) |
| 2023/Q3 | 2023-11-09 | -- | ±29.85% | -18.83% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:50:20 · For reference only, not investment advice and not tailored to your situation.
GoodRx discussion 0 comments